We are live on ! Find out more
ACPU

Arrowgrass Capital Partners (US) Portfolio holdings

AUM $380M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+20.87%
3 Year Est. Return
+55.83%
5 Year Est. Return
+146.17%
10 Year Est. Return
AUM
$8.32B
AUM Growth
+$103M
Cap. Flow
-$907M
Cap. Flow %
-10.9%
Top 10 Hldgs %
45.44%
Holding
503
New
97
Increased
114
Reduced
110
Closed
110

Sector Composition

Rank Sector Weight
1 Healthcare 13.21%
2 Technology 12.91%
3 Industrials 5.34%
4 Communication Services 2.79%
5 Energy 2.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
51
Kinder Morgan
KMI
$71.7B
$24.7M 0.3%
1,385,657
+491,298
+55% +$8.04M
IWM icon
52
CALL
iShares Russell 2000 ETF
IWM
$79.8B
$24.3M 0.29%
2,200
+1,540
+233% +$159K
UNH icon
53
PUT
UnitedHealth
UNH
$376B
$23.7M 0.28%
1,836
+1,457
+384% +$172K
RAD
54
DELISTED
Rite Aid Corporation
RAD
$23.1M 0.28%
141,843
-1,371,073
-91% -$216M
AUMA
55
DELISTED
AR CAPITAL ACQUISITION CORP COMMON STOCK
AUMA
$23.1M 0.28%
2,346,011
+75,000
+3% +$734K
C icon
56
PUT
Citigroup
C
$222B
$23.1M 0.28%
5,530
-1,250
-18% -$52.2K
TGT icon
57
PUT
Target
TGT
$65.6B
$22.5M 0.27%
2,739
+1,527
+126% +$115K
BIIB icon
58
PUT
Biogen
BIIB
$30B
$22.3M 0.27%
858
+658
+329% +$174K
MU icon
59
Micron Technology
MU
$930B
$22.1M 0.27%
2,114,745
+422,505
+25% +$4.72M
CTXS
60
DELISTED
Citrix Systems Inc
CTXS
$21.9M 0.26%
349,641
+138,078
+65% +$7.81M
HAL icon
61
PUT
Halliburton
HAL
$26.9B
$21.8M 0.26%
6,108
-190
-3% -$6.2K
BIIB icon
62
CALL
Biogen
BIIB
$30B
$21.4M 0.26%
823
+473
+135% +$125K
PFE icon
63
PUT
Pfizer
PFE
$143B
$20.8M 0.25%
7,400
+7,009
+1,793% +$200K
BLVD
64
DELISTED
Boulevard Acquisition Corp. II Class A Common Stock
BLVD
$20.2M 0.24%
2,075,220
+41,000
+2% +$396K
SYT
65
DELISTED
Syngenta Ag
SYT
$19.9M 0.24%
+240,647
New +$18.9M
ILMN icon
66
Illumina
ILMN
$31B
$19.6M 0.24%
124,231
-37,553
-23% -$5.74M
TWNK
67
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$19.6M 0.24%
+2,005,320
New +$19.4M
AGN
68
CALL
DELISTED
Allergan plc
AGN
$19.2M 0.23%
716
-55
-7% -$15.7K
XOM icon
69
PUT
ExxonMobil
XOM
$644B
$19.1M 0.23%
2,290
+1,540
+205% +$123K
MDLZ icon
70
CALL
Mondelez International
MDLZ
$79.5B
$19M 0.23%
4,742
+4,656
+5,414% +$190K
MS icon
71
PUT
Morgan Stanley
MS
$331B
$18.6M 0.22%
7,442
+844
+13% +$21.5K
PG icon
72
PUT
Procter & Gamble
PG
$336B
$18.4M 0.22%
2,233
+474
+27% +$38.2K
MRK icon
73
PUT
Merck
MRK
$322B
$18.1M 0.22%
3,591
+2,085
+138% +$102K
JNJ icon
74
CALL
Johnson & Johnson
JNJ
$618B
$17.1M 0.2%
1,576
-1,002
-39% -$104K
EFII
75
DELISTED
Electronics for Imaging
EFII
$17M 0.2%
400,274
+61,611
+18% +$2.51M

Similar funds

Arrowgrass Capital Partners (US)'s Q1 2016 Portfolio in Review

As of Q1 2016, Arrowgrass Capital Partners (US) held 503 positions worth $8.32B, up 1.2% from $8.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Arrowgrass Capital Partners (US) withdrew a net $907M in Q1 2016, closing 110 positions and reducing 110 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $517M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 9% a quarter earlier, followed by Technology and Industrials.

Against the trend, Arrowgrass Capital Partners (US) opened a new position in BAXALTA INC COM STK (DE) worth $372M.

  • Arrowgrass Capital Partners (US)'s largest Q1 2016 buy was BAXALTA INC COM STK (DE): 9,217,534 shares worth $372M.
  • Arrowgrass Capital Partners (US) added most to Allergan plc in Q1 2016, an estimated $300M increase.
  • Arrowgrass Capital Partners (US)'s biggest Q1 2016 reduction was Rite Aid Corporation, cutting an estimated $216M.
  • Arrowgrass Capital Partners (US) fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $517M.
  • Arrowgrass Capital Partners (US)'s ten largest holdings make up 45% of its $8.32B portfolio in Q1 2016.
  • Arrowgrass Capital Partners (US) opened 97 new positions and closed 110 in Q1 2016.
  • Arrowgrass Capital Partners (US)'s portfolio value rose 1.2% quarter-over-quarter to $8.32B.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2016, filed 16 May 2016.